You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康恩貝(600572.SH):公司經營受目前市面上中藥材大幅升價的影響較小
格隆匯 09-15 20:31

格隆匯9月15日丨康恩貝(600572.SH)在半年度業績説明會上表示,今年市場上中藥材價格普遍上升,鑑於公司通過自建和與其他單位合作形式建設了中藥材種植基地,如公司在江西種植了地錦草、樟樹根、香薷,為公司的“康恩貝”牌腸炎寧提供主要中藥材原料;在四川、廣西種植魚腥草,為“金笛”牌複方魚腥草合劑提供主要原料。種植基地還能提供金毛耳草、銀杏葉、夏天無、浙貝母、元胡等優質藥材資源,保障了公司中成藥產品的主要原料供應。因此,公司經營受目前市面上中藥材大幅升價的影響較小,今年整體的成本預計將維持在可控範圍內。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account